Second Interim Analysis of PALLAS Adjuvant Study for HR+, HER2- Early Breast Cancer Demonstrates That There is Little Chance of Palbociclib Reducing the Risk of Recurrence

Vienna, Brussels, Chicago, Philadelphia, Neu-Isenburg/Frankfurt, Pittsburgh, May 29, 2020 -- The Austrian Breast & Colorectal Cancer Study Group (ABCSG), Alliance Foundation Trials (AFT), the Breast International Group (BIG), PrECOG, LLC, the German Breast Group, and the NSABP Foundation today announced that the independent Data Monitoring Committee (IDMC) for the global Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant Study (PALLAS) trial determined that the study is unlike


2020 Fall Group Meeting
- November 5-7

2021 Spring & Fall Group Meetings
- May 13-15 & November 4-6

All meetings are open to all
Alliance members and will be held
at Loews Chicago O'Hare Hotel